Divis Laboratories Sees 20,963 Call Contracts Trade at Rs 6500 Strike Price
Divis Laboratories Ltd has become one of the most actively traded stocks, with significant call contract activity and a notable performance, outperforming its sector. Despite a decline in investor participation, the stock maintains strong liquidity and continues to show resilience in the pharmaceutical market.
Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today. The company’s underlying stock, DIVISLAB, has shown significant trading activity with 20,963 call contracts traded, reflecting a turnover of approximately Rs 2,730.01 lakhs. The options, set to expire on October 28, 2025, have a strike price of Rs 6,500, while the underlying value stands at Rs 6,496.In terms of performance, Divis Laboratories has outperformed its sector by 4.7%, marking a notable trend with consecutive gains over the past four days, resulting in an impressive 11.52% return during this period. The stock reached an intraday high of Rs 6,507.5, representing a 6.12% increase. Additionally, Divis Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
However, it is worth noting a decline in investor participation, with delivery volume dropping by 52.25% compared to the 5-day average. Despite this, the stock remains liquid enough for trades sized at Rs 7.72 crore, reflecting its robust market position. Overall, Divis Laboratories continues to demonstrate resilience and activity in the market, underscoring its significance in the pharmaceutical landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
